๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to evaluate and compare the efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00276458
Treatments Being Tested
This study investigates the safety, pharmacokinetics and effects of GSK1292...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-14
Trial ID
NCT01218204
To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin ...
Status
Completed
Location
Gangdong Sacred Heart Hospital
Start Date
2019-06-11
Trial ID
NCT04584736
Treatments Being Tested
Ezetimibe exerts its primary effects by inhibiting intestinal cholesterol a...
Status
Recruiting
Location
Severance hospital, Yonsei University College of Medicine
Start Date
2024-02-28
Trial ID
NCT06784557
Treatments Being Tested
A phase โ ข, multi-center, randomized, double-blinded, active comparator, fac...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-04
Trial ID
NCT02749994
Treatments Being Tested
Rationale: Patients with acute coronary syndromes are at an increased risk...
Status
Recruiting
Location
Aswan Heart Centre
Start Date
2021-03-24
Trial ID
NCT04701242
Treatments Being Tested
A study to assess the effectiveness and tolerability of MK0653A and MK0653A...
Status
Completed
Location
Multiple Locations
Start Date
2005-01-19
Trial ID
NCT00541697
The purpose of this study is to assess the effects of Ezetimibe on coronary...
Status
Unknown
Location
Yokohama City University Medical Center
Start Date
2010-10
Trial ID
NCT01068093
Treatments Being Tested
The study is a placebo-controlled, double-blind, randomized, phase 3 study ...
Status
Completed
Location
East Valley Diabetes & Endocrinology
Start Date
2024-03-01
Trial ID
NCT06005597
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2022-01-01
Trial ID
NCT06225635
Treatments Being Tested